Mallinckrodt Plc
(Other OTC/NBB : MNK)

( )
MNK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 8.39%47.650.0%$182.73m
HZNPHorizon Therapeutics Plc 3.53%102.045.4%$177.52m
VRXValeant Pharmaceuticals International, Inc. 3.49%25.1914.1%$148.22m
CTLTCatalent, Inc. 2.18%123.502.0%$130.63m
ICLRICON plc 4.76%278.592.8%$113.63m
CPIXCumberland Pharmaceuticals, Inc. -17.58%5.720.6%$81.06m
JAZZJazz Pharmaceuticals Plc 1.88%123.792.1%$79.06m
UTHRUnited Therapeutics Corp. 0.90%190.4113.9%$73.23m
PRGOPerrigo Co. Plc 0.97%37.406.9%$67.14m
BHCBausch Health Cos., Inc. 3.49%25.190.0%$61.53m
ARGXargenx SE 4.86%292.520.0%$59.83m
ENDPEndo International Plc 4.98%5.278.5%$34.16m
PCRXPacira Biosciences, Inc. 4.99%56.809.8%$26.44m
QLGNQualigen Therapeutics, Inc. 7.63%1.270.0%$26.25m
IRWDIronwood Pharmaceuticals, Inc. 2.23%11.449.5%$25.83m

Company Profile

Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes innovative specialty pharmaceutical brands. The Specialty Generics segment relates to niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.